Sign In
Buy COR
$263.64
-1.20 (-0.453%)
At Close: Jun 03, 2026
Here's Why You Should Hold Cencora Stock in Your Portfolio for Now
03:51pm, Friday, 20'th Sep 2024
COR continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
Here's Why Cencora (COR) is a Strong Growth Stock
10:50am, Monday, 09'th Sep 2024
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Camino and Nittetsu Extend Again by One Additional Week Exclusive Rights to Negotiate Copper Mine Acquisition in Chile
06:00am, Friday, 06'th Sep 2024
VANCOUVER, BC / ACCESSWIRE / September 6, 2024 / Camino Minerals Corporation (TSXV:COR)(OTC PINK:CAMZF) (WKN:A116E1) ("Camino" or the "Company") and Nittetsu Mining Co., Ltd. ("Nittetsu") announce a o
Why Is Cencora (COR) Down 2.8% Since Last Earnings Report?
12:37pm, Friday, 30'th Aug 2024
Cencora (COR) reported earnings 30 days ago. What's next for the stock?
Here's Why Cencora (COR) is a Strong Value Stock
10:41am, Friday, 30'th Aug 2024
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Camino and Nittetsu Extend by One Week Exclusive Rights to Negotiate Copper Mine Acquisition in Chile
06:00am, Friday, 30'th Aug 2024
VANCOUVER, BC / ACCESSWIRE / August 30, 2024 / Camino Minerals Corporation (TSXV:COR)(OTC PINK:CAMZF)(WKN:A116E1) (" Camino " or the " Company ") and Nittetsu Mining Co., Ltd. (" Nittetsu ") announce
Is Walgreens Ready To Rebound?
10:59am, Friday, 23'rd Aug 2024
Walgreens issued $750 million in senior unsecured notes at 8.125%, refinancing 3.800% notes due in 2024, leading to a $32.4 million increase in annual interest costs. Walgreens sold its remaining Cenc
Cencora (COR) Gains 16.6% YTD: What's Driving the Stock?
02:16pm, Thursday, 22'nd Aug 2024
Cencora (COR) gaining traction from the robust U.S. Healthcare Solutions segment raises optimism about the stock.
Why Cencora (COR) is a Top Growth Stock for the Long-Term
10:46am, Thursday, 22'nd Aug 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Reasons to Hold Cencora (COR) Stock in Your Portfolio for Now
08:25am, Wednesday, 21'st Aug 2024
Cencora (COR) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
Here's Why Cencora (COR) is a Strong Momentum Stock
10:51am, Friday, 16'th Aug 2024
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Cencora (COR) is a Top Value Stock for the Long-Term
10:46am, Wednesday, 14'th Aug 2024
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Cencora, Inc. (COR) Hit a 52 Week High, Can the Run Continue?
10:15am, Monday, 05'th Aug 2024
Cencora (COR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Walgreens continues to shed stake in Cencora as it looks to bolster turnaround
01:59pm, Friday, 02'nd Aug 2024
Struggling drug-store chain Walgreens Boots Alliance Inc. has sold off shares of drug distributor Cencora Inc., handing the retailer some $1.1 billion in proceeds as it tries to carry out a turnaround
All You Need to Know About Cencora (COR) Rating Upgrade to Buy
01:01pm, Friday, 02'nd Aug 2024
Cencora (COR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
